Auris Medical Provides Update on Intranasal Betahistine Development Program

Phase 1b trial with AM-201 proceeding as planned to data read-out in early May 2020

Enrollment into Phase 2 trial with AM-125 impacted by COVID-19 pandemic

Company to report 2019 second-half and full year results and provide general business update on April 16, 2020 A 

Hamilton, Bermuda, April 3, 2020 a?? Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today provided an update on the impact of the COVID-19 pandemic on its ongoing clinical trials with intranasal betahistine.The Phase 1b trial with AM-201, intranasal betahistine for the prevention of antipsychotic-induced weight gain and somnolence, has remained unaffected by the COVID-19 pandemic. The last subject had its last treatment visit in early March 2020. The trial is now progressing towards the read-out of top-line data, which is expected for early May 2020, in accordance with previous guidance.A  A A The Phase 2 trial with AM-125, intranasal betahistine for the treatment of acute peripheral vertigo, will be impacted by the COVID-19 outbreak. The outbreak has delayed enrollment into the study. Candidates for participation in this trial undergo certain types of neurosurgery, which are classified as elective procedures. Due to the COVID-19 outbreak, the sites participating in the a??TRAVERSa?? trial have postponed elective procedures and temporarily reduced or suspended clinical research activities. As a result, enrollment came to a halt towards the end of March 2020. Although sites are expected to catch up on enrollment once COVID-19 related restrictions are relaxed, the Company expects that the interim analysis following Part A of the trial will now be completed in the third quarter of 2020, at the earliest.The Company expects to report its 2019 second-half and full year results and to provide a general business update on April 16, 2020.About Betahistine
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Июнь 2020    »